Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Summary

This study will test the safety, tolerance, and efficacy of different doses of oral gallium maltolate. Patients will receive oral gallium maltolate twice daily for 28-consecutive days followed by 14 days off treatment. This dosing cycle will be repeated. Adverse effects will be assessed and the levels of gallium in serum will be measured. Any effect of the drug on the cancer and any improvement in cancer-related symptoms will also be measured.

Timeline

Start

2001-06

Primary completion

2005-03

Completion

2005-03

Drugs

Indications